Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 24, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on understanding liver health issues in women with Turner Syndrome (TS), a genetic condition that affects development. Researchers want to find out how common liver problems are in adults with TS and what factors might contribute to these issues. They will look at both lab tests and imaging studies to see how the liver is functioning and if there are any visible changes. The findings could help improve our understanding of liver health in TS and guide future treatments.

To be eligible for the study, participants must be women aged 18 years or older who have been diagnosed with Turner Syndrome through a blood test. It's important that they are not currently taking any medications that could significantly affect liver function. Those who join the trial will contribute to valuable research that may lead to better management of liver health in individuals with Turner Syndrome. Participants will need to provide written consent to take part in the study.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of Turner syndrome made by karyotype analysis on peripheral blood.
• • Age 18 years or older
• • Written informed consent obtained
• Exclusion Criteria:
• • TS patients on therapy with drugs responsible for significant liver enzyme alterations (liver function alteration, LFA).